We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD (Allo)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02221622
Recruitment Status : Recruiting
First Posted : August 20, 2014
Last Update Posted : April 20, 2017
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Roberta Brinton, University of Southern California

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2017
  Estimated Study Completion Date : December 2017